| Print
Krystal Biotech (KRYS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Address
2100 Wharton Street
Suite 701
Pittsburgh
PA
USA
15203
Telephone
+1 412 586-5830
Forecast key dates
| Name | Key Date |
|---|---|
| Krystal Biotech Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-03T08:30:00 |
| Krystal Biotech Inc Third Quarter Earnings Results for 2026 | 2026-11-03T00:00:00 |
| Krystal Biotech Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-04T08:30:00 |
| Krystal Biotech Inc Second Quarter Earnings Results for 2026 | 2026-08-04T00:00:00 |
| Krystal Biotech Inc Annual General Meeting for 2026 | 2026-05-15T16:00:00 |
| Krystal Biotech Inc First Quarter Earnings Conference Call for 2026 | 2026-05-06T08:30:00 |
| Krystal Biotech Inc First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
| Krystal Biotech Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-19T08:30:00 |
| Krystal Biotech Inc Annual Report for 2025 | 2026-02-19T00:00:00 |
| Krystal Biotech Inc Fourth Quarter Earnings Results for 2025 | 2026-02-19T00:00:00 |
| 8th Annual Evercore Healthcare Conference | 2025-12-03T10:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.